Monday, 16 December 2013

Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes

Patients switching to glargine pen achieved lower HbA1c at 6 months of follow-up. Patients in both groups overwhelmingly preferred glargine pens over vial-syringe (Endocrine Practice)


Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes

Discontinuation (or switching) of OADs at the time of insulin initiation appears to be governed principally by concerns about hypoglycaemia and weight. HbA1c improvements were smaller in patients discontinuing OADs at the time of insulin initiation and may be associated with insufficient insulin titration (Journal of Clinical Pharmacy and Therapeutics)

No comments:

Post a Comment